SG11201407328TA - Compositions and methods for the treatment of moderate to severe pain - Google Patents

Compositions and methods for the treatment of moderate to severe pain

Info

Publication number
SG11201407328TA
SG11201407328TA SG11201407328TA SG11201407328TA SG11201407328TA SG 11201407328T A SG11201407328T A SG 11201407328TA SG 11201407328T A SG11201407328T A SG 11201407328TA SG 11201407328T A SG11201407328T A SG 11201407328TA SG 11201407328T A SG11201407328T A SG 11201407328TA
Authority
SG
Singapore
Prior art keywords
international
pain
compositions
moderate
publication
Prior art date
Application number
SG11201407328TA
Other languages
English (en)
Inventor
Mahesh Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Publication of SG11201407328TA publication Critical patent/SG11201407328TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201407328TA 2012-07-03 2013-06-23 Compositions and methods for the treatment of moderate to severe pain SG11201407328TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2682CH2012 2012-07-03
PCT/IB2013/055146 WO2014006529A2 (fr) 2012-07-03 2013-06-23 Compositions et méthodes de traitement de la douleur modérée à aiguë

Publications (1)

Publication Number Publication Date
SG11201407328TA true SG11201407328TA (en) 2014-12-30

Family

ID=54188020

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407328TA SG11201407328TA (en) 2012-07-03 2013-06-23 Compositions and methods for the treatment of moderate to severe pain

Country Status (8)

Country Link
EP (1) EP2870130A4 (fr)
JP (1) JP2015527309A (fr)
CN (1) CN104583162A (fr)
AU (1) AU2013285126A1 (fr)
CA (1) CA2873018A1 (fr)
SG (1) SG11201407328TA (fr)
WO (1) WO2014006529A2 (fr)
ZA (1) ZA201408057B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2873094A1 (fr) * 2012-05-07 2013-11-14 Cellixbio Private Limited Promedicaments d'agents antiplaquettaires
WO2016046674A1 (fr) * 2014-09-28 2016-03-31 Mohan M Alapati Compositions et procédés pour le traitement de douleur modérée à aiguë
CN105037241B (zh) * 2015-06-19 2018-02-23 上海上药新亚药业有限公司 1‑(2,6‑二氯苯基)‑2‑吲哚酮的合成工艺
CN111116391A (zh) * 2019-12-17 2020-05-08 浙江工业大学 一种2-[(2,6-二氯苯基)氨基]苯乙酸钠的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137301C (fr) * 1966-03-30
AU514991B2 (en) * 1976-05-26 1981-03-12 Commonwealth Of Australia, The Pharmaceutical compositions containing antiinflammatory analgesic compounds
LU78106A1 (de) * 1977-05-11 1979-05-23 Ciba Geigy Ag Verfahren zur herstellung neuer substituierter phenylessigsaeureamidverbindungen
JPS5412340A (en) * 1977-06-27 1979-01-30 Daito Koeki Process for preparing phenylacetate derivative
NL8602767A (nl) * 1986-10-31 1988-05-16 Gantax Nv Organisch zuuranhydride, alsmede farmaceutisch preparaat op basis van een prodrug.
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH1143467A (ja) * 1997-05-14 1999-02-16 Ikeda Mohandou:Kk 脂肪酸グリセライド誘導体及びグリセライド誘導体、並びにそれらの製造方法
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
CN101868443A (zh) * 2007-09-20 2010-10-20 特拉维夫大学拉莫特有限公司 N-苯基邻氨基苯甲酸衍生物及其用途
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac
CN101186583B (zh) * 2007-12-20 2011-05-11 吉林大学 2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
BRPI0901298A2 (pt) * 2009-04-06 2011-01-04 Ems Sa derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
US9525998B2 (en) * 2012-01-06 2016-12-20 Qualcomm Incorporated Wireless display with multiscreen service
JP6097766B2 (ja) * 2012-01-27 2017-03-15 インターデイジタル パテント ホールディングス インコーポレイテッド マルチキャリアベースおよび／または疑似照合ネットワークにおいてｅｐｄｃｃｈを提供するためのシステムおよび／または方法
CA2873094A1 (fr) * 2012-05-07 2013-11-14 Cellixbio Private Limited Promedicaments d'agents antiplaquettaires
JP2015519333A (ja) * 2012-05-07 2015-07-09 セリックスビオ プライヴェート リミテッド 神経疾患の治療のための組成物および方法
SG11201407309XA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy
SG11201407314XA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of diabetes
JP2015533114A (ja) * 2012-05-08 2015-11-19 セリックスビオ プライヴェート リミテッド 神経疾患の治療のための組成物及び方法
EP2847175A4 (fr) * 2012-05-08 2016-04-20 Cellix Bio Private Ltd Compositions et méthodes inhibant l'activité de l'anhydrase carbonique

Also Published As

Publication number Publication date
CA2873018A1 (fr) 2014-01-09
CN104583162A (zh) 2015-04-29
WO2014006529A2 (fr) 2014-01-09
EP2870130A2 (fr) 2015-05-13
ZA201408057B (en) 2016-03-30
JP2015527309A (ja) 2015-09-17
AU2013285126A1 (en) 2014-11-27
EP2870130A4 (fr) 2015-12-02
WO2014006529A3 (fr) 2014-04-24

Similar Documents

Publication Publication Date Title
SG11201407326XA (en) Compositions and methods for treatment of mucositis
SG11201408094YA (en) Neprilysin inhibitors
SG11201805838UA (en) Macrocyclic mcl1 inhibitors for treating cancer
SG11201407037UA (en) Catechol o-methyltransferase activity inhibiting compounds
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201408739VA (en) Inhibitors of hepatitis c virus
SG11201907891XA (en) Combination therapy for the treatment or prevention of tumours
SG11201407537YA (en) Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
SG11201408769QA (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
SG11201407303SA (en) Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
SG11201407533SA (en) Antiviral compounds
SG11201408629QA (en) Dimethyl-benzoic acid compounds
SG11201407411SA (en) Compositions and methods for the treatment of metabolic syndrome
SG11201408133TA (en) Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
SG11201407546QA (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
SG11201804867RA (en) Coating compositions and treating method
SG11201407591PA (en) Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
SG11201407189XA (en) C-17 bicyclic amines of triterpenoids with hiv maturation inhibitory activity
SG11201909376TA (en) Crystalline forms of a jak inhibitor compound
SG11201805387RA (en) Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
SG11201408685WA (en) Antibacterial microelement chelates and the use thereof in animal feeds
SG11201407319YA (en) Compositions and methods for treatment of inflammatory bowel disease
SG11201408750VA (en) NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
SG11201809560QA (en) Enhancer of zeste homolog 2 inhibitors
SG11201407317SA (en) Compositions and methods for suppression of carbonic anhydrase activity